JOURNAL OF MEDICINE CARE AND HEALTH REVIEW

Abstract

The advent of artificial intelligence (AI) is ushering in a "tailored treatment revolution" in healthcare, fundamentally shifting the paradigm from generalized approaches to personalized interventions. This paper explores how AI's analytical capabilities are being leveraged to create individualized treatment plans, considering a patient's unique genetic, clinical, and lifestyle data. By analyzing vast datasets, AI algorithms can identify intricate patterns and predict treatment responses with unprecedented accuracy. This enables clinicians to optimize drug dosages, select the most effective therapies, and anticipate potential adverse effects. We examine the application of AI in various medical domains, including oncology, cardiology, and neurology, highlighting its role in enhancing treatment precision and patient outcomes. Furthermore, we discuss the ethical considerations and challenges associated with AI-driven personalized medicine, including data privacy, algorithmic bias, and the need for robust validation. This review underscores the transformative potential of AI in shaping the future of healthcare, where treatments are precisely tailored to individual patient needs.

Keywords: Artificial intelligence (AI), personalized medicine, tailored treatment, precision medicine, healthcare, drug discovery, treatment planning, predictive analytics, genomics, clinical data, machine learning, ethical considerations.

►AI and the Tailored Treatment Revolution in Healthcare

Patrik Kennet^1*, Soren Falkner²

¹Massachusetts Institute of Technology, Massachusetts Ave, Cambridge, MA 02139, United States.

²Vienna University of Technology, Faculty of Computer Engineering, Vienna, Austria.

The traditional "one-size-fits-all" approach to medicine, while foundational, often falls short in addressing the diverse and nuanced needs of individual patients. Significant variations in genetic makeup, lifestyle, environmental exposures, and disease progression contribute to differential responses to therapies. Recognizing this heterogeneity, the medical community is increasingly embracing the concept of personalized or precision medicine, aiming to tailor treatments to each patient's unique characteristics [1-22]. At the heart of this transformative shift lies artificial intelligence (AI), a powerful tool poised to revolutionize healthcare by enabling the "tailored treatment revolution."

AI's ability to analyze vast and complex datasets, identify intricate patterns, and generate predictive models is fundamentally changing how we approach patient care. By leveraging machine learning algorithms, AI can process and integrate diverse data sources, including genomic information, clinical records, imaging data, and even wearable sensor data, to create comprehensive patient profiles. This holistic view enables clinicians to move beyond generalized treatment protocols and develop individualized strategies that optimize therapeutic efficacy while minimizing adverse effects.

The potential of AI in personalized medicine is particularly evident in oncology. Cancer, a disease characterized by significant inter- and intra-tumoral heterogeneity, demands a highly individualized approach. AI algorithms can analyze genomic data to identify specific tumor mutations and predict the likelihood of response to targeted therapies. This allows oncologists to select the most effective drugs for each patient, avoiding unnecessary exposure to ineffective or toxic treatments. Furthermore, AI-powered imaging analysis can track tumor growth and response to therapy in real-time, enabling timely adjustments to treatment plans.

Beyond oncology, AI is transforming other medical domains as well. In cardiology, AI algorithms can analyze electrocardiograms (ECGs) and echocardiograms to identify subtle patterns that may indicate an increased risk of heart disease. This allows for early intervention and personalized prevention strategies. In neurology, AI can analyze brain imaging data to predict the progression of neurodegenerative diseases, enabling the development of personalized rehabilitation programs. And in pharmacogenomics, AI [23-40] is used to predict how individual patients will metabolize and respond to different medications, optimizing drug dosages and minimizing the risk of adverse drug reactions.

The ability of AI to personalize treatment extends beyond drug selection and dosage optimization. AI-powered tools can also assist in the development of personalized rehabilitation programs, tailored to individual patient needs and recovery trajectories. For example, AI-driven virtual reality platforms can provide interactive and engaging rehabilitation exercises, adapting to patient progress in real-time. Moreover, AI can play a crucial role in patient monitoring and follow-up care. Wearable sensors and mobile apps, integrated with AI algorithms, can collect continuous data on patient activity, vital signs, and symptoms, enabling remote monitoring and early detection of potential complications.

However, the implementation of AI-driven personalized medicine is not without its challenges. One critical concern is data privacy and security. The vast amounts of sensitive patient data required to train AI algorithms raise concerns about the potential for unauthorized access and misuse. Robust data protection measures and ethical guidelines are essential to ensure patient trust and compliance with regulations. Another challenge is algorithmic bias. AI models trained on biased datasets can perpetuate and even amplify existing disparities in healthcare. Addressing this issue requires careful curation of training data and rigorous evaluation of AI models on diverse patient populations.

Furthermore, the "black box" nature of some AI algorithms can hinder clinical adoption. Clinicians may be hesitant to rely on models whose decision-making processes are opaque. Explainable AI (XAI) techniques, which aim to make AI algorithms more transparent and interpretable, are crucial for building trust and facilitating clinical integration. Finally, the regulatory landscape for AI-powered medical devices is still evolving. Clear guidelines and streamlined approval processes are needed to ensure the safe and effective deployment of these technologies.

Despite these challenges, the potential of AI to revolutionize healthcare through personalized medicine is undeniable. By leveraging AI's analytical capabilities [41-60], we can move towards a future where treatments are precisely tailored to individual patient needs, leading to improved outcomes, reduced healthcare costs, and a more equitable and efficient healthcare system. The "tailored treatment revolution" is underway, and AI is poised to be its driving force.

Challenges

Several challenges must be addressed to ensure its successful and ethical implementation. These hurdles span technical, ethical, and practical domains, requiring careful consideration and proactive solutions.

1. Data Quality, Availability, and Interoperability

• Data Silos and Fragmentation: Healthcare data is often fragmented across disparate systems, hindering the creation of comprehensive patient profiles. Achieving interoperability between these systems is crucial for seamless data integration.
• Data Quality and Standardization: The quality and consistency of healthcare data can vary significantly, impacting the accuracy and reliability of AI models. Standardized data formats and quality control measures are essential.
• Data Volume and Accessibility: Training robust AI models [61-80] requires vast amounts of high-quality data, which may not always be readily available or accessible due to privacy concerns or institutional restrictions.
• Data Privacy and Security: The sensitive nature of patient data necessitates stringent security measures to prevent unauthorized access and breaches. Compliance with regulations like HIPAA and GDPR is paramount.

2. Algorithmic Bias and Generalizability

• Bias in Training Data: AI models can inherit biases present in their training data, leading to disparities in treatment recommendations across different demographic groups. Ensuring diverse and representative training datasets is critical.
• Lack of Generalizability: Models trained on data from specific populations or institutions may not generalize well to other settings, limiting their applicability.
• "Black Box" Problem and Explainability: The complexity of some AI models, particularly deep learning algorithms, makes it difficult to understand their decision-making processes. This lack of transparency can hinder clinician trust and adoption.
• Validation and Reproducibility: Rigorous validation and reproducibility studies are essential to ensure the reliability and safety of AI-driven treatment recommendations.

3. Clinical Integration and Workflow

• Clinician Acceptance and Trust: Clinicians may be hesitant to adopt AI tools due to concerns about accuracy, reliability, and the potential for job displacement. Building trust and demonstrating the value of AI through evidence-based studies is crucial.
• Integration with Existing Systems: Seamless integration of AI tools into existing clinical workflows and electronic health record (EHR) systems is essential for efficient implementation.
• Lack of Standardization: The absence of standardized protocols and guidelines for the development and validation of AI algorithms can hinder their widespread adoption.
• Clinical Decision Support Integration: AI needs to be delivered in a way that seamlessly integrates with the clinician's workflow, and doesn't add undue burden.

4. Ethical and Legal Considerations

• Liability and Accountability: Determining liability in cases where AI-powered tools make diagnostic or treatment errors is a complex legal issue.
• Informed Consent: Obtaining informed consent from patients regarding the use of AI in their care is essential.
• Algorithmic Transparency and Explainability: The "black box" nature of some AI models raises ethical concerns about transparency and accountability.
• Potential for Job Displacement: The automation of tasks performed by clinicians raises concerns about the potential for job displacement.
• Equitable Access: Ensuring equitable access to AI-driven personalized medicine for all patient populations is crucial to avoid exacerbating existing healthcare disparities.

5. Regulatory and Economic Challenges

• Regulatory Hurdles: Navigating the complex regulatory landscape for AI-powered medical devices can be challenging, requiring clear guidelines and streamlined approval processes.
• Cost-Effectiveness and Reimbursement: Demonstrating the cost-effectiveness of AI-driven personalized medicine and establishing appropriate reimbursement models are essential for its widespread adoption.
• Infrastructure Requirements: Implementing AI-driven personalized medicine requires significant investments in computational infrastructure, data storage, and skilled personnel.
• Keeping Up with Rapid Advancement: The field of AI [81-99] is rapidly evolving, and healthcare systems need to adapt to keep pace with these advancements.

Advantages and Disadvantages of AI in the Tailored Treatment Revolution

The integration of artificial intelligence (AI) into personalized medicine offers a spectrum of potential benefits, but also presents several disadvantages that must be carefully considered.

Advantages

• Enhanced Personalization
  • AI's ability to analyze vast and diverse datasets enables the creation of highly individualized treatment plans, considering factors like genetics, lifestyle, and medical history.
  • This leads to more precise drug selection, optimized dosages, and targeted therapies, improving treatment efficacy.
• Improved Predictive Accuracy
  • AI algorithms can identify subtle patterns and predict treatment responses with greater accuracy than human clinicians, leading to earlier interventions and better outcomes.
  • Predictive analytics can anticipate potential adverse effects and complications, allowing for proactive management.
• Accelerated Drug Discovery and Development
  • AI can analyze large datasets to identify potential drug targets and predict the efficacy of new therapies, speeding up the drug discovery process.
  • This can lead to the development of more personalized and effective medications.
• Enhanced Diagnostic Capabilities
  • AI-powered imaging analysis and data mining can detect subtle disease markers and patterns that may be missed by human observers, leading to earlier and more accurate diagnoses.
  • This is particularly valuable in complex diseases like cancer and neurodegenerative disorders.
• Increased Efficiency and Cost-Effectiveness
  • AI can automate routine tasks, such as data analysis and report generation, freeing up clinicians to focus on patient care.
  • This can lead to increased efficiency and reduced healthcare costs.
• Improved Patient Monitoring and Management
  • AI-powered wearable sensors and mobile apps can collect continuous patient data, enabling remote monitoring and early detection of potential complications.
  • This improves chronic disease management.
• Data Driven Insights
  • AI has the capacity to comb through massive amounts of data and find correlations that would be impossible for a human to find [100-103]. This allows for new insights into diseases and treatments.

Disadvantages

• Data Privacy and Security Concerns
  • The collection and analysis of sensitive patient data raises significant privacy and security concerns.
  • Robust data protection measures and ethical guidelines are essential to prevent unauthorized access and misuse.
• Algorithmic Bias and Disparities
  • AI models trained on biased datasets can perpetuate and even amplify existing disparities in healthcare.
  • Ensuring diverse and representative training datasets is crucial to mitigate this risk.
• Lack of Transparency and Explainability
  • The "black box" nature of some AI algorithms can hinder clinician trust and adoption.
  • Explainable AI (XAI) techniques are needed to make AI decisions more transparent and interpretable.
• Clinical Integration Challenges
  • Integrating AI tools into existing clinical workflows and electronic health record (EHR) systems can be complex and challenging.
  • Clinician acceptance and trust are essential for successful implementation.
• Regulatory and Legal Uncertainty
  • The regulatory landscape for AI-powered medical devices is still evolving, creating uncertainty for developers and clinicians.
  • Clear guidelines and streamlined approval processes are needed.
• Potential for Job Displacement
  • The automation of tasks performed by clinicians raises concerns about the potential for job displacement.
  • Retraining and adaptation of the workforce will be crucial.
• Dependence and Overreliance
  • There is a risk that clinicians could become over-reliant on AI, and lose critical thinking skills.
  • AI should be a tool to augment, not replace, human expertise.

Future Works

The field of AI in personalized medicine is rapidly evolving, presenting numerous opportunities for future research and development. Here are some key areas for future exploration:

1. Enhanced AI Models and Algorithms

• Multi-Modal Data Integration
  • Developing AI models that can seamlessly integrate and analyze diverse data types, including genomics, proteomics, metabolomics, imaging, and electronic health records (EHRs), to create comprehensive patient profiles.
  • Exploring deep learning architectures that can effectively handle the complexity and heterogeneity of multi-modal data.
• Explainable AI (XAI)
  • Developing XAI techniques that can provide transparent and interpretable explanations for AI-driven treatment recommendations, fostering clinician trust and facilitating clinical adoption.
  • Focusing on developing methods to visualize and communicate AI decision-making processes to clinicians and patients.
• Causal Inference
  • Developing AI models that can infer causal relationships between patient characteristics and treatment outcomes, enabling more accurate prediction of treatment response.
  • Moving beyond correlational analysis to identify the underlying mechanisms driving treatment efficacy.
• Federated Learning and Privacy-Preserving AI
  • Developing federated learning algorithms that can train AI models on decentralized data without compromising patient privacy.
  • Exploring privacy-preserving AI techniques, such as differential privacy and homomorphic encryption, to enable secure data sharing and analysis.

2. Clinical Integration and Implementation

• Development of Clinical Decision Support Systems (CDSS)
  • Integrating AI-powered treatment recommendations into CDSS that seamlessly integrate with existing clinical workflows and EHR systems.
  • Developing user-friendly interfaces that facilitate clinician interaction with AI tools.
• Real-Time Patient Monitoring and Intervention
  • Developing AI-driven systems for real-time patient monitoring using wearable sensors and mobile apps.
  • Developing algorithms that can detect early signs of treatment response or adverse effects and trigger timely interventions.
• Personalized Rehabilitation and Remote Care
  • Developing AI-powered virtual reality platforms and robotic systems for personalized rehabilitation programs.
  • Exploring the use of AI for remote patient monitoring and care, particularly for chronic disease management.
• AI-Driven Clinical Trials
  • Use AI to optimize patient selection and trial design.
  • Use AI to analyze trial data in order to accelerate the time it takes to bring new treatments to market.

3. Ethical and Societal Considerations

• Algorithmic Bias Mitigation
  • Developing methods for detecting and mitigating algorithmic bias in AI models, ensuring equitable access to personalized medicine for all patient populations.
  • Focusing on developing diverse and representative training datasets.
• Data Governance and Security
  • Establishing robust data governance frameworks and security measures to protect sensitive patient information.
  • Developing ethical guidelines for the use of AI in personalized medicine.
• Patient Education and Engagement
  • Developing educational programs to inform patients about the benefits and risks of AI-driven personalized medicine.
  • Engaging patients in the development and implementation of AI tools.
• Legal and Regulatory Frameworks
  • Developing clear legal and regulatory frameworks for the development and deployment of AI-powered medical devices and treatments.
  • Addressing issues related to liability, accountability, and informed consent.

4. Expanding Applications

• Mental Health:
  • Developing AI tools that can analyze speech patterns, facial expressions, and other data to personalize mental health treatments.
• Rare Diseases:
  • Leveraging AI to analyze limited data on rare diseases and accelerate the development of personalized treatments.
• Preventative Medicine:
  • Use AI to predict the likelihood of future diseases and develop personalized prevention plans.

Conclusion

The "tailored treatment revolution," powered by artificial intelligence, is poised to reshape the landscape of healthcare. By leveraging AI's analytical prowess to decipher the intricate tapestry of individual patient data, we are moving beyond the limitations of generalized medicine and towards a future where treatments are precisely aligned with unique biological and clinical profiles. This paradigm shift holds immense promise for improving treatment efficacy, minimizing adverse effects, and ultimately, enhancing patient outcomes.

The advantages are clear: AI enables the creation of highly personalized treatment plans, improves predictive accuracy, accelerates drug discovery, and enhances diagnostic capabilities. However, the path to realizing this vision is not without its challenges. Data privacy and security, algorithmic bias, clinical integration complexities, and ethical considerations demand careful attention and proactive solutions.

To fully harness the transformative potential of AI in personalized medicine, future research must focus on developing more robust and transparent AI models, integrating multi-modal data, and addressing the ethical and societal implications of this technology. Clinical integration, patient engagement, and the establishment of clear regulatory frameworks are equally crucial.

1. 1. Maryam Gholizadeh, Dr Omid Panahi. (2021). Investigating System in Health Management Information Systems, Scholars Press Academic Publishing. ISBN: 978- 613-8-95240-4.
   2. Maryam Gholizadeh, Dr Omid Panahi. (2021). Untersuchungssystem im Gesund heits management Informations systeme, Unser wissen Publishing. ISBN: 978-620-3-67046-2.
   3. Maryam Gholizadeh, Dr Omid Panahi. (2021). Sistema de investigación en sistemas de información de gestión sanitaria, NUESTRO CONOC, MENTO Publishing. ISBN: 978-620-3-67047-9.
   4. Maryam Gholizadeh, Dr Omid Panahi. (2021). Système d'investigation dans les systèmes d'information de gestion de la santé, EDITION NOTRE SAVOIR Publishing. ISBN: 978-620-3-67048-6.
   5. Maryam Gholizadeh, Dr Omid Panahi. (2021). Indagare il sistema nei sistemi informativi di gestione della salute, SAPIENZA Publishing. ISBN: 978-620-3-67049-3.
   6. Maryam Gholizadeh, Dr Omid Panahi. (2021). Systeemonderzoek in Informatiesystemen voor Gezondheidsbeheer, ONZE KENNIS Publishing. ISBN: 978-620-3-67050-9.
   7. Maryam Gholizadeh, Dr Omid Panahi. (2021). System badawczy w systemach informacyjnych zarządzania zdrowiem, NAZSA WIEDZA Publishing. ISBN: 978-620-3-67051-6.
   8. Omid Panahi, Alireza Azarfardin. Computer-Aided Implant Planning: Utilizing AI for Precise Placement and Predictable Outcomes.Journal of Dentistry and Oral Health. 2(1). 
   9. Maryam Gholizadeh, Dr Omid Panahi. (2021). Sistema de Investigação em Sistemas de Informação de Gestão de Saúde, NOSSO CONHECIMENTO Publishing. ISBN: 978-620-3-67052-3.
   10. Maryam Gholizadeh, Dr Omid Panahi. (2021). Система исследований в информационных системах управления здравоохранением , SCIENCIA SCRIPTS Publishing. ISBN: 978-620-3-67053-0.
   11. Dr Leila Ostovar, Dr Kamal Khadem Vatan, Dr Omid Panahi. (2020). Clinical Outcome of Thrombolytic Therapy, Scholars Press Academic Publishing. ISBN: 978-613-8- 92417-3.
   12. Dr Omid Panahi. (2019). Nanotechnology, Regenerative Medicine and Tissue Bioengineering. Scholars Press Academic Publishing. ISBN: 978-613-8-91908-7.
   13. Samira Zarei, Dr Omid Panahi, Dr NimaBahador. (2019). Antibacterial activity of aqueous extract of eucalyptus camaldulensis against Vibrio harveyi (PTCC1755) and Vibrio alginolyticus (MK641453.1). Saarbucken: LAP, Lambert Academic Publishing GmbH & Co.KG. ISBN: 978-620-0-48110-8.
   14. Samira Zarei, Dr Omid Panahi. (2019). Eucalyptus camaldulensis Extract as a Preventive to the Vibriosis, Scholars Press Academic Publishing. ISBN: 978-613-8- 91935-3.
   15. Panahi, O. (2024). Dental Implants & the Rise of AI. On J Dent & Oral Health. 8(1): 2024.
   16. Omid P, Sevil Farrokh E. (2025). Bioengineering Innovations in Dental Implantology. Curr Trends Biomedical Eng&Biosci. 23(3): 556111.
   17. Panahi, P, Bayılmış, C, Çavuşoğlu, U, Kaçar, S. (2021). Performance evaluation of lightweight encryption algorithms for IoT-based applications. Arabian Journal for Science and Engineering. 46(4): 4015-4037.
   18. Panahi, U, Bayılmış, C. (2023). Enabling secure data transmission for wireless sensor networks based IoT applications. Ain Shams Engineering Journal. 14(2): 101866.
   19. Omid Panahi, and UrasPanahi. (2025). AI-Powered IoT: Transforming Diagnostics and Treatment Planning in Oral Implantology. J AdvArtifIntell Mach Learn. 1(1): 1-4.
   20. Panahi O. (2025). The Algorithmic Healer: AI's Impact on Public Health Delivery. MediClin Case Rep J. 3(1): 759-762.
   21. Panahi O. (2025). The Future of Healthcare: AI, Public Health and the Digital Revolution. MediClin Case Rep J. 3(1): 763-766.
   22. Panahi O, Raouf MF, Patrik K. (2011). The evaluation between pregnancy and peridontal therapy Int J Acad Res. 3:1057–1058.
   23. Panahi O, Melody FR, Kennet P, Tamson MK. (2011). Drug induced (calcium channel blockers) gingival hyperplasia. JMBS. 2(1):10-12.
   24. Omid P. (2011). Relevance between gingival hyperplasia and leukemia. Int J Acad Res. 3:493–494. 
   25. Omid PANAHI and Fatmanur KETENCİ ÇAY. (2023). “NanoTechnology, Regenerative Medicine and, Tissue Bio-Engineering". Acta Scientific Dental
       Sciences. 7(4): 118-122.
   26. Omid Panahi. (2024). “Dental Pulp Stem Cells: A Review". Acta Scientific Dental Sciences 8(2): 22-24.
   27. DrUrasPanahi. (2025). AD HOC Networks: Applications, Challenges, Future Directions, Scholars' Press, ISBN: 978-3-639-76170-2.
   28. Omid Panahi. Artificial intelligence in Dentistry, Scholars Press Academic Publishing.
   29. PejmanPanahi. (2011). Michelle Freund, SAFETY APPLICATION SCHEMA FOR VEHICULAR VIRTUAL AD HOC GRID NETWORKS, International Journal of Academic Research. 3(2).
   30. PejmanPanahi. (2009). New Plan for Hardware Resource Utilization in Multimedia Applications Over Multi Processor Based System, MIPRO 2009, 32nd International Convention Conference on GRID AND VISUALIZATION SYSTEMS (GVS), 256-260.
   31. Dr Omid Panahi, Dr Sevil Farrokh Eslamlou. Peridontium: Struktur, Funktion und klinisches Management, ISBN:978-620-8-74556-1.
   32. Dr Omid Panahi, Dr Sevil Farrokh Eslamlou. Peridoncio: Estructura, función y manejo clínico, ISBN:978-620-8-74557-8.
   33. Dr Omid Panahi, Dr Sevil Farrokh Eslamlou. Le péridontium: Structure, fonction et gestion clinique, ISBN:978-620-8-74558-5.
   34. Dr Omid Panahi, Dr Sevil Farrokh Eslamlou. Peridonio: Struttura, funzione e gestione clinica, ISBN:978-620-8-74559-2.
   35. Dr Omid Panahi, Dr Sevil Farrokh Eslamlou. Peridontium: Struktura, funkcja i postępowanie kliniczne, ISBN:978-620-8-74560-8.
   36. bakikoyuncu, pejmanpanahi. (2014). Kalman Filtering of Link Quality Indicator Values for Position Detection by Using WSNS, Int'l Journal of Computing, Communications & Instrumentation Engg. (IJCCIE). 1.
   37. Panahi O. (2025). The Algorithmic Healer: AI's Impact on Public Health Delivery. MediClin Case Rep J. 3(1): 759-762.
   38. Panahi O. (2025). The Future of Healthcare: AI, Public Health and the Digital Revolution. MediClin Case Rep J. 3(1): 763-766.
   39. PANAHI, O. (2013). Comparison between unripe Makopa fruit extract on bleeding and clotting time. International Journal of Paediatric Dentistry. 23: 205.
   40. Panahi, O, Arab, M. S, Tamson, K. M. (2011). GINGIVAL ENLARGMENT AND RELEVANCE WITH LEUKEMIA. International Journal of Academic Research. 3(2).
   41. Dr Omid Panahi.(2021). Stammzellen aus dem Zahnmark. ISBN: 978-620-4-05355-4.
   42. Dr Omid Panahi. (2021). Células madre de la pulpa dental. ISBN: 978-620-4-05356-1.
   43. Dr Omid Panahi. Стволовые клетки пульпы зуба. ISBN: 978-620-4-05357-8.
   44. Dr Omid Panahi. (2021). Cellules souches de la pulpe dentaire. ISBN: 978-620-4-05358-5.
   45. Dr Omid Panahi. (2021). Cellule staminali della polpa dentaria. ISBN: 978-620-4-05359-2.
   46. Dr Omid Panahi. (2021). Células estaminais de polpa dentária. ISBN: 978-620-4-05360-8.
   47. Panahi, O, Melody, F. R. (2011). A NOVEL SCHEME ABOUT EXTRACTION ORTHODONTIC AND ORTHOTHERAPY. International Journal of Academic Research. 3(2).
   48. PANAHI, O, NUNAG, G.M, NOURINEZHAD SIYAHTAN, A. (2011). MOLECULAR PATHOLOGY: P-115: CORRELATION OF HELICOBACTER PYLORI AND PREVALENT INFECTIONS IN ORAL CAVITY. CELL JOURNAL (YAKHTEH), 12(SUPPLEMENT 1 (THE 1ST INTERNATIONAL STUDENT CONGRESS ON CELL AND MOLECULAR MEDICINE)), 91-92. SID.
   49. Panahi, P, Bayılmış, C, Çavuşoğlu, U, Kaçar, S. (2018). “Performance Evaluation of L-Block Algorithm for IoT Applications”, 3. UluslararasıBilgisayarBilimleri veMühendisliğiKonferansı (UBMK). 609-612.
   50. Panahi, P, Bayılmış, C, Çavuşoğlu, U, Kaçar, S. (2019). “Comparing PRESENT and LBlock block ciphers over IoT Platform”, 12th International Conference on Information Security and Cryptology. 66-69.
   51. Panahi,U.(2022). "Nesnelerininternetiiçinhafifsıkletkriptolojialgoritmalarınadayalıgüvenlihaberleşmemodelitasarımı" SakaryaÜniversitesi, Fen BilimleriEnstitüsü, Sakarya.
   52. BakiKoyuncu, PejmanPanahi, SefikaVarlioglu. (2015). Comparative Indoor Localization by using Landmarc and Cricket Systems, International Journal of Emerging Technology and Advanced Engineering (IJETAE). 5(6):453-456.
   53. Dr Omid Panahi, Dr Sevil Farrokh Eslamlou, Dr Masoumeh Jabbarzadeh. (2025). Digitale Zahnmedizin und künstliche Intelligenz, ISBN: 978-620-8-73910-2.
   54. Dr Omid Panahi, Dr Sevil Farrokh Eslamlou, Dr Masoumeh Jabbarzadeh. (2025). Odontología digital e inteligencia artificial, ISBN: 978-620-8-73911-9.
   55. Dr Omid Panahi, Dr Sevil Farrokh Eslamlou, Dr Masoumeh Jabbarzadeh. (2025). Dentisterie numérique et intelligence artificielle, ISBN: 978-620-8-73912-6.
   56. Dr Omid Panahi, Dr Sevil Farrokh Eslamlou, Dr Masoumeh Jabbarzadeh. (2025). Odontoiatria digitale e intelligenza artificiale, ISBN: 978-620-8-73913-3.
   57. Dr Omid Panahi, Dr Sevil Farrokh Eslamlou, Dr Masoumeh Jabbarzadeh. Stomatologia cyfrowa i sztuczna inteligencja, ISBN: 978-620-8-73914-0.
   58. Dr Omid Panahi, Dr Sevil Farrokh Eslamlou, Dr Masoumeh Jabbarzadeh. (2025). Medicina dentária digital e inteligência artificial, ISBN: 978-620-8-73915-7.
   59. Dr Omid Panahi and Dr Masoumeh Jabbarzadeh. (2025). The Expanding Role of Artificial Intelligence in Modern Dentistry. On J Dent & Oral Health. 8(3).
   60. Omid P, Shabnam D. (2025). Mitigating Aflatoxin Contamination in Grains: The Importance of Postharvest Management Practices. Adv Biotech & Micro. 18(5): 555996.
   61. Omid Panahi, Ali Ezzati. (2025). AI in Dental-Medicine: Current Applications & Future Directions. Open Access J Clin Images. 2(1): 1-5.
   62. Koyuncu, B, Gokce, A, Panahi, P. (2015). Reconstruction of an Archeological site in real time domain by using software techniques. In 2015 Fifth International Conference on Communication Systems and Network Technologies. 1350-1354. IEEE.
   63. Omid P, Soren F. (2025). The Digital Double: Data Privacy, Security, and Consent in AI Implants West J Dent Sci 2(1): 105.
   64. Dr Uras Panahi. (2025). Redes AD HOC: Aplicações, Desafios, Direcções Futuras, Edições Nosso Conhecimento. ISBN: 978-620-8-72962-2.
   65. Dr Uras Panahi. (2025). Sieci AD HOC: Zastosowania, wyzwania, przyszłe kierunki, Wydawnictwo Nasza Wiedza. ISBN: 978-620-8-72967-7.
   66. Dr Uras Panahi. Reti AD HOC: Applicazioni, sfide e direzioni future, Edizioni Sapienza, ISBN: 978-620-8-72965-3.
   67. Dr Omid Panahi, Dr Sevil Farrokh Eslamlou. (2025). Peridontium: Estrutura, função e gestão clínica, lSBN: 978-620-8-74561-5.
   68. Dr Omid Panahi, Dr Shabnam Dadkhah. AI in der modernen Zahnmedizin. ISBN:978-620-8-74877-7.
   69. Dr Omid Panahi, Dr Shabnam Dadkhah. La IA en la odontología moderna, ISBN:978-620-8-74881-4.
   70. Dr Omid Panahi, Dr Shabnam Dadkhah. L'IA dans la dentisterie moderne, ISBN:978-620-8-74882-1.
   71. Dr Omid Panahi, Dr Shabnam Dadkhah. L'intelligenza artificiale nell'odontoiatria moderna, ISBN:978-620-8-74883-8.
   72. Dr Omid Panahi, Dr Shabnam Dadkhah. Sztuczna inteligencja w nowoczesnej stomatologii, ISBN:978-620-8-74884-5.
   73. Dr Omid Panahi, Dr Shabnam Dadkhah. A IA na medicina dentária moderna, ISBN:978-620-8-74885-2.
   74. Dr Uras Panahi. (2025). Redes AD HOC: Aplicaciones, retos y orientaciones futuras, Ediciones Nuestro Conocimiento, ISBN: 978-620-8-72966-0.
   75. Dr Uras Panahi. (2025). Réseaux AD HOC: Applications, défis et orientations futures, Editions Notre Savoir, ISBN: 978-620-8-72964-6.
   76. Dr Uras Panahi. (2025). AD HOC-Netze: Anwendungen, Herausforderungen, zukünftige Wege, Verlag Unser Wissen, ISBN: 978-620-8-72963-9.
   77. Panahi, O. (2025). The Role of Artificial Intelligence in Shaping Future Health Planning. Int J Health Policy Plann. 4(1): 01-05.
   78. Panahi, O. (2025). AI in Health Policy: Navigating Implementation and Ethical Considerations. Int J Health Policy Plann. 4(1): 01-05.
   79. Panahi, O. (2024). Dental Implants & the Rise of AI. On J Dent & Oral Health. 8(1): 2024.
   80. Panahi O and Falkner S. (2025). Telemedicine, AI, and the Future of Public Health. Western J Med Sci & Res. 2(1): 102.
   81. Panahi, O. (2025). Innovative Biomaterials for Sustainable Medical Implants: A Circular Economy Approach. European Journal of Innovative Studies and Sustainability. 1(2): 1-5.
   82. Panahi, O. (2025). Wearable Sensors and Personalized Sustainability: Monitoring Health and Environmental Exposures in Real-Time. European Journal of Innovative Studies and Sustainability. 1(2): 1-5. 
   83. Panahi O. (2025). AI-Enhanced Case Reports: Integrating Medical Imaging for Diagnostic Insights. J Case Rep Clin Images. 8(1): 1161.
   84. Panahi O. (2025). AI and IT in Medical Imaging: Case Reports. J Case Rep Clin Images. 8(1): 1160.
   85. Omid Panahi. (2025). “Robotics in Implant Dentistry: Current Status and Future Prospects". Scientific Archives Of Dental Sciences 7(9): 55-60.
   86. Omid P, Soren F. (2025). The Digital Double: Data Privacy, Security, and Consent in AI Implants. Digit J Eng Sci Technol 2(1): 105.
   87. O. Panahi. (2025). Algorithmic Medicine, Journal of Medical Discoveries, 2(1).
   88. O. Panahi. (2025). Deep Learning in Diagnostics, Journal of Medical Discoveries, 2(1).
   89. Panahi, O. (2025). AI in Health Policy: Navigating Implementation and Ethical Considerations. Int J Health Policy Plann. 4(1): 01-05.
   90. Panahi, O. (2025). The Role of Artificial Intelligence in Shaping Future Health Planning. Int J Health Policy Plann. 4(1): 01-05.
   91. Panahi, O. (2025). Secure IoT for Healthcare. European Journal of Innovative Studiesand Sustainability. 1(1): 1-5.
   92. Omid P, Evil Farrokh E. (2024). Beyond the Scalpel: AI, Alternative Medicine, and the Future of Personalized Dental Care. J Complement Med Alt Healthcare. 13(2): 555860.
   93. Panahi, O, Farrokh, S. (2025). Ethical Considerations of AI in Implant Dentistry: A Clinical Perspective. J Clin Rev Case Rep. 10(2): 01-05.
   94. Dr Omid Panahi, Dr Ali Ezzati and DrMansourehZeynali. (2025). Will AI Replace Your Dentist? The Future of Dental Practice. OnJ Dent & Oral Health. 8(3).
   95. Panahi O. (2025). Navigating the AI Landscape in Healthcare and Public Health. Mathews J Nurs. 7(1): 56.
   96. Dr Omid Panahi, Dr Faezeh Esmaili, Dr Sasan Kargarnezhad. (2024). Künstliche Intelligenz in der Zahnmedizin,  Unser wissen Publishing. ISBN: 978-620-3-6722696.
   97. Dr Omid Panahi, Dr Faezeh Esmaili, Dr Sasan Kargarnezhad. (2024). Artificial Intelligence in Dentistry, Scholars Press Publishing. ISBN: 978-620-6772118. (English Edition).
   98. Dr Omid Panahi, Dr Faezeh Esmaili, Dr Sasan Kargarnezhad. (2024). Inteligencia artificial en odontología, NUESTRO CONOC, MENTO Publishing. ISBN: 978-620-6622764.
   99. Dr Omid Panahi, Dr Faezeh Esmaili, Dr Sasan Kargarnezhad. (2024). L'intelligence artificielle dans l'odontologie, EDITION NOTRE SAVOIR Publishing Publishing. ISBN: 978-620-6622771.
   100. Dr Omid Panahi, Dr Faezeh Esmaili, Dr Sasan Kargarnezhad. (2024). Intelligenza artificiale in odontoiatria, SAPIENZA Publishing. ISBN: 978-620-6622788.(Italian Edition).
   101. Dr Omid Panahi, Dr Faezeh Esmaili, Dr Sasan Kargarnezhad. (2024). Inteligência Artificial em Medicina Dentária, NOSSO CONHECIMENTO Publishing. ISBN: 978-620-6622795.
   102. Dr Omid Panahi, Dr Faezeh Esmaili, Dr Sasan Kargarnezhad. (2024). Искусственный интеллект в стоматологии, SCIENCIA SCRIPTS Publishing. ISBN: 978-620-6622801.
   103. Dr Shima Esmaielzadeh, Dr Omid Panahi, Dr Fatmanur Ketenci Çay. (2020). Application of Clay’s in Drug Delivery in Dental Medicine, Scholars Press Academic Publishing. ISBN:978-613-8-94058-6.

Download Provisional PDF Here